Association between nintedanib adherence trajectory and healthcare use among idiopathic pulmonary fibrosis patients.

Poor adherence to nintedanib was associated with all-cause hospitalizations and medical costs. Therefore, improved adherence programs, such as support programs, can be implemented to reduce economic burden.